Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALQA

Alliqua Biomedical (ALQA) Stock Price, News & Analysis

Alliqua Biomedical logo

About Alliqua Biomedical Stock (NASDAQ:ALQA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$3.23
52-Week Range
N/A
Volume
371,516 shs
Average Volume
114,400 shs
Market Capitalization
$13.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALQA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliqua Biomedical and its competitors with MarketBeat's FREE daily newsletter.

ALQA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

ALQA Stock Analysis - Frequently Asked Questions

Alliqua Biomedical Inc (NASDAQ:ALQA) announced its quarterly earnings data on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of ($2.70) by $3.20. The business had revenue of $5.50 million for the quarter, compared to analyst estimates of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.

Alliqua Biomedical shares reverse split before market open on Friday, October 6th 2017.The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliqua Biomedical investors own include Palatin Technologies (PTN), ContraVir Pharmaceuticals (CTRV), Argos Therapeutics (ARGSQ), Consolidated Water (CWCO), Bristol Myers Squibb (BMY), Biopharmx (BPMX) and Ritter Pharmaceuticals (RTTR).

Company Calendar

Last Earnings
8/09/2016
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ALQA
CIK
1054274
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.42 million
Net Margins
-230.50%
Pretax Margin
N/A
Return on Equity
-71.73%
Return on Assets
-55.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.28
Quick Ratio
8.17

Sales & Book Value

Annual Sales
$2.22 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,010,000
Free Float
N/A
Market Cap
$13.46 million
Optionable
Not Optionable
Beta
2.03
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ALQA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners